Figure 8From: Renoprotective capacities of non-erythropoietic EPO derivative, ARA290, following renal ischemia/reperfusion injuryThe effect of ARA290 on structural damage. No differences were found between controls or ARA290 treated groups in α-SMA mRNA (A) or cortical protein expression (B).Back to article page